Editing Perelman School of Medicine (section)

== Research ==

Perelman faculty conduct research generating over $900 million in annual funding, supporting investigations from molecular biology to population health. Research strengths include cancer (through the Abramson Cancer Center), cardiovascular disease, neuroscience, immunology, and gene therapy, where Penn researchers have pioneered approaches including CAR-T cell therapy. Research discoveries have produced multiple approved treatments and fundamentally advanced understanding of disease processes.<ref name="perelman"/>

The school's research enterprise integrates with clinical care through translational programs that move discoveries from laboratory to patient. Clinical trials enroll thousands of patients in studies evaluating new treatments, while research findings inform care throughout Penn Medicine's clinical network. This integration of research and care distinguishes academic medical centers from community hospitals while generating advances that eventually benefit patients everywhere.<ref name="perelman"/>